Skip to main content

Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion

NT-pro-BNP Plasmaspiegel bei Vorhofflimmern vor und nach elektrischer Kardioversion

Zeitschrift für Kardiologie volume 94, pages 795–800 (2005)Cite this article

Zusammenfassung

Hintergrund

In mehreren Studien wurden natriuretische Peptide (ANP, BNP) bei Patienten mit persistierendem Vorhofflimmern vor und nach elektrischer Kardioversion ermittelt. Häufig bestand bei den untersuchten untersuchten Patienten jedoch additiv eine Herzinsuffizienz, welche die Interpretation der natriuretischen Peptide hinsichtlich des Vorhofflimmerns erschwert. Ziel dieser Studie war es, die Serumkonzentrationen von NT-pro-BNP, welches das stabilere Abspaltungsprodukt von pro-BNP darstellt, bei Patienten mit persistierendem Vorhofflimmern, aber normaler linksventrikulärer Ejektionsfraktion, vor und nach elektrischer Kardioversion zu bestimmen.

Patienten und Methoden

Es wurden NT-pro-BNP-Plasmaspiegel von 34 konsekutiven Patienten vor, wenige Minuten nach und 11 Tage nach elektrischer Kardioversion bestimmt. Alle Patienten wiesen nach echokardiographischen oder lävokardiographischen Kriterien eine normale linksventrikuläre Ejektionsfraktion auf.

Ergebnisse

Im Vergleich zu einem gesunden Kontrollkollektiv zeigte sich das NT-pro-BNP mit einem Medianwert von 1086 pg/ml vs. 66,9 pg/ml signifikant erhöht (p<0,001). Nach einer mittleren Beobachtungszeit von 11 Tagen wiesen Patienten mit anhaltendem Sinusrhythmus einen Abfall des NT-pro-BNP von 1071 pg/ml zu 300 pg/ml auf (p<0,001). Im Gegensatz dazu wiesen Patienten mit einem Vorhofflimmern Rezidiv eine Erhöhung der NT-pro-BNP-Plasmaspiegel von 1570,5 pg/ml zu 1991 pg/ml auf (n.s. p=0,13). Die NT-pro-BNP-Spiegel vor elektrischer Kardioversion zeigten bei Patienten mit oder ohne Rezidiv keinen signifikanten Unterschied (p=0,23).

Zusammenfassung

Patienten mit Vorhofflimmern und normaler linksventrikuärer Ejektionsfraktion zeigten im Vergleich zu einer gesunden Kontrollgruppe ein signifikant erhöhtes NT-pro-BNP. Nach elektrischer Kardioversion war bei Patienten mit Sinusrhythmus ein signifikanter Abfall des NT-pro-BNP nachweisbar, während bei Patienten mit Rezidiv eines Vorhofflimmerns ein erhöhtes (n.s.) NT-pro-BNP messbar war. Da Patienten mit Sinusrhythmus oder Rezidiv eines Vorhofflimmerns vor Kardioversion kein signifikant unterschiedliches NT-pro-BNP aufwiesen, scheint NT-pro-BNP keinen prädiktiven Wert für das Auftreten eines Rezidivs zu besitzen.

Summary

Objective

Plasma levels of brain natriuretic peptide (BNP) have been examined in studies on patients with persistent atrial fibrillation, both before and after electrical cardioversion. Studied patients often showed a comorbidity with congestive heart failure, which complicates interpretation of measured BNP values as a natriuretic peptide. The aim of this study was to examine plasma levels of N-terminal fragment pro-brain natriuretic peptide (NT-pro-BNP), which is the more stable but inactive cleavage product of pro-BNP in patients with atrial fibrillation, but normal left ventricular ejection fraction, before and after electrical cardioversion.

Patients and methods

NT-pro-BNP plasma levels of 34 consecutive patients were measured before, shortly after and 11 days after electrical cardioversion. All patients showed a normal ejection fraction after echocardiographic or laevocardiographic criteria.

Results

At baseline, all patients showed elevated NT-pro-BNP compared to a healthy control group (1086 vs. 66.9 pg/ml, p<0.001). After a mean follow-up time of 11 days in patients with persistent restored sinusrhythm, NT-pro-BNP decreased from 1071 pg/ml at baseline to 300 pg/ml (p<0.001). In contrast, patients with recurrence of atrial fibrillation showed increased levels from 1570.5 pg/ml at baseline to 1991 pg/ml (p=0.13; n.s.). Recurrence of atrial fibrillation was independent from height of NT-pro-BNP levels at baseline (p=0.23).

Conclusions

Atrial fibrillation in patients with a normal left ventricular ejection fraction is associated with elevated NT-pro-BNP plasma levels, which decrease when a persistent sinus-rhythm can be restored by electrical cardioversion. On the other hand, NT-pro-BNP seems to increase (n.s.) when recurrence of atrial fibrillation occurs. Finally, NT-pro-BNP is no valid predictor for long-term success of sinus-rhythm restoration by electrical cardioversion.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H (2004) Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 20:1245–1248

    PubMed  CAS  Google Scholar 

  2. Bonow RO (1996) New insights into the cardia natriuretic peptides. Circulation 93:1946–1950

    PubMed  CAS  Google Scholar 

  3. Clerico A, Del Ry S, Giannessi D (2000) Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practise: the need for a new generation of immunoassay methods. Clin Chem 46:1529–1534

    PubMed  CAS  Google Scholar 

  4. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD (1996) Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 77:828–831

    PubMed  Article  CAS  Google Scholar 

  5. Dickstein K, Larsen AI, Bonarjee V, Thoresen M, Aarsland T, Hall C (1995) Plasma proatrial natriuretic factor is predicitve of clinical status in patients with congestive heart failure. Am J Cardiol 76:679–683

    PubMed  Article  CAS  Google Scholar 

  6. Ellinor PT, Low AF, Patton KK, Shea MA, MacRae CA (2005) Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. J Am Coll Cardiol 45:82–86

    PubMed  Article  CAS  Google Scholar 

  7. Henry WL, Morganroth J, Pearlman AS et al (1976) Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53:273–279

    PubMed  CAS  Google Scholar 

  8. Hess G, Moeck J, Zdunek D (2005) N-Terminal-proBNP (NT-pro-BNP) as an indicator of cardiac dysfunction. Z Kardiol 94:247–254

    PubMed  Article  CAS  Google Scholar 

  9. Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation—Pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 356:1789–1794

    PubMed  Article  CAS  Google Scholar 

  10. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T (2000) Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Failure 6:92–96

    Article  CAS  Google Scholar 

  11. Lubien E, DeMarla A, Krishnaswamy P et al (2002) Utility of B-natriurtic peptide in detecting diastolic dysfunction: comparison with doppler velocity recordings. Circulation 105:595–601

    PubMed  Article  CAS  Google Scholar 

  12. Maisel AS, Krishnaswamy P, Nowak RM et al; for the Breathing not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167

    PubMed  Article  CAS  Google Scholar 

  13. Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, Munson JT, Douglas PS (1994) Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23:1535–1540

    PubMed  Article  CAS  Google Scholar 

  14. Ogawa Y, Tamura N, Chusho H, Nakao K (2001) Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can J Physiol Pharmacol 79:723–729

    PubMed  Article  CAS  Google Scholar 

  15. Ohta Y, Shimada T, Yoshitomi H, Inoue S, Murakami Y, Shimizu H, Nakamura K, Ohta T, Katoh H, Ishibashi Y (2001) Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 17:415–420

    PubMed  CAS  Google Scholar 

  16. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833

    Article  Google Scholar 

  17. Tse HF, Lau CP (2003) Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion. Pacing Clin Electrophysiol 26:1809–1814

    PubMed  Article  Google Scholar 

  18. Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, Meyer TE, Rosenthal LS, Aurigemma GP (2004) Brain natriuretic peptide levels fall rapidly after cardioversion of atrial firbillation to sinus rhythm. Cardiology 102:188–193

    PubMed  Article  CAS  Google Scholar 

  19. Wozakowska-Kaplon B, Opolski G (2003) Concomitant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 41:1716–1720

    PubMed  Article  CAS  Google Scholar 

  20. Wozakowska-Kaplon B (2004) Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 93:1555–1558

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. HELIOS-Klinikum Wuppertal, Universitätsklinikum der Universität Witten-Herdecke, Herzzentrum Kardiologie, Medizinische Klinik III, Arrenberger Str. 20, 42117, Wuppertal, Germany

    D.-I. Shin, Ph. Schley, A. Sause, M. Müller, R. Fueth, H. Guelker & M. Horlitz

  2. Institut für Herz-Kreislaufforschung, Universität Witten-Herdecke, Arrenberger Str. 20, 42117, Wuppertal, Germany

    K. Jaekel & T. Scheffold

Authors
  1. D.-I. Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Jaekel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ph. Schley
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Sause
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Fueth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Scheffold
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Guelker
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Horlitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D.-I. Shin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shin, DI., Jaekel, K., Schley, P. et al. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. ZS Kardiologie 94, 795–800 (2005). https://doi.org/10.1007/s00392-005-0301-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-005-0301-7

Schlüsselwörter

  • NT-pro-BNP
  • Vorhofflimmern
  • elektrische Kardioversion

Key words

  • NT-pro-BNP
  • atrial fibrillation
  • electrical cardioversion